Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Stoschitzky Gergana |

Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen

Glantschnig, T; Posch, F; Firla, S; Moik, F; Ablasser, K; Binder, JS; Stoschitzky, G; Wallner, M; Von Lewinski, D; Stoger, H; Zirlik, A; Pichler, M; Rainer, PP Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+early breast cancer undergoing trastuzumab-based therapy
WIEN KLIN WOCHENSCHR. 2019; 131: 292-293. [Poster]
Web of Science

 

Sieghartsleitner, R; Toth-Gayor, G; Zweiker, D; Manninger, M; Odeneg, T; Mastnak, B; Ablasser, K; Verheyen, N; Stoschitzky, G; Maier, R; Luha, O; Brussee, H; Scherr, D Is there an impact of left atrial appendage morphology on the incidence of peri device leaks?
WIEN KLIN WOCHENSCHR. 2018; 130: 118-118. [Poster]
Web of Science

 

Verheyen, N; Stoschitzky, G; Binder, J; Ablasser, K; Knez, I; Dapunt, O; Gamillscheg, A; Maier, R Unexpected blood flow from pulmonary veins during cardiopulmonary bypass for mitral valve surgery in a 62-year-old woman
WIEN KLIN WOCHENSCHR. 2018; 130: 49-51. [Poster]
Web of Science

 

Verheyen, NN; Stoschitzky, G; Binder, J; Ablasser, K; Dapunt, O; Knez, I; Gamillscheg, A; Maier, R Unexpected blood flow from pulmonary veins during cardiopulmonary bypass for mitral valve surgery in a 62-year-old woman
EUR J HEART FAIL. 2018; 20: 347-347. [Poster]
Web of Science

 

Sieghartsleitner, R; Toth-Gayor, G; Zweiker, D; Manninger, M; Odeneg, T; Mastnak, B; Ablasser, K; Stoschitzky, G; Maier, R; Luha, O; Brussee, H; Scherr, D Indications for and outcome with the left atrial appendage occluder - a single center experience
WIEN KLIN WOCHENSCHR. 2017; 129 (Suppl 1): S97. 2017; -ÖKG Jahrestagung; JUN 7-10, 2017; Salzburg, AUSTRIA. [Poster]

 

Ablasser K; Stoschitzky G; Schmidt A; Fruhwald F. Prescription rates and dosage of heart failure medication varies dramatically in woman, with age and comorbidities
European Journal of Heart Failure. 2015; 17(Suppl ):341-341.-Heart Failure 2015; MAY 23-26, 2015; Seville, SPAIN. [Poster]
Web of Science

 

Kresoja, KP; Maier, R; Stoschitzky, G; Binder, J; Kapl, M; Marte, W; Brussee, H; Luha, O; Schmidt, A Percutaneous treatment strategy in patients with severe aortic stenosis and concomitant coronary artery disease: a 30-day outcome single-center analysis
WIEN KLIN WOCHENSCHR. 2015; 127: S21-S21. [Oral Communication]
Web of Science

 

Ablasser, K; Platzer, V; Heller, S; Stoschitzky, G, Schmidt, A; Pieske, B; Fruhwald, F ESC heart failure guideline conform prescription rates and dosage of heart failure medication varies significantly in patients hospitalized for heart failure compared to outpatient treated.
Wiener Klinische Wochenschrift. 2013; 125(Suppl ):29-29.-Jahrestagung der Österreichischen Kardiologischen Gesellschaft; JUN 5-8, 2013; Salzburg, AUSTRIA. [Poster]

 

Paetzold, S; Luha, O; Hoedl, R; Stoschitzky, G; Zweiker, R; Schmidt, A; Zweiker, D; Paetzold, D; Pieske, B; Maier, R; Durability of transcatheter aortic valve implantation: single-center experience and four-year follow-up.
CIRCULATION. . 2012; 125(19):E665-E665.-World Congress of Cardiology Scientific Sessions; APR 18-21, 2012; Dubai, U ARAB EMIRATES. [Poster]
Web of Science

 

Stoschitzky, K; Stoschitzky, G; Pieske, B; No evidence of nitrate tolerance with Nicorandil.
EUR HEART J. . 2012; 33: 470-470.-Congress of the European-Society-of-Cardiology (ESC); AUG 25-29, 2012; Munchen, GERMANY. [Poster]
Web of Science

 

Paetzold, S; Luha, O; Hoedl, R; Stoschitzky, G; Pfeiffer, K; Zweiker, D; Pieske, B; Maier, R Single-center experience with transcatheter aortic valve implantation and echocardiographic follow-up.
Eur J Echocardiography. 2011; 12(S2):ii101-ii101.-Euroecho & other Imaging Modalities; DEZ 7-10, 2011; Budapest, HUNGARY. [Poster]

 

Patzold, S; Luha, O; Hodl, R; Stoschitzky, G; Pfeiffer, K; Schmidt, A; Zweiker, R; Zweiker, D; Pieske, B; Maier, R Cumulative survival after transcatheter aortic valve implantation: Single-center three-year follow-up
WIEN KLIN WOCHENSCHR. 2011; 123(17-18):A62-A62. [Poster]
Web of Science

 

Pätzold, S; Luha, O; Hödl, R; Stoschitzky, G; Pfeiffer, KP; Zweiker, D; Pieske, BM; Maier, R Single-center experience with transcatheter aortic valve implantation: cumulative survival and 3-year follow-up.
J Kardiol. 2011; 18(5-6):187-187.-Jahrestagung 2011 der Österreichischen Kardiologischen Gesellschaft; MAY 25-28, 2011; Salzburg, AUSTRIA. [Oral Communication]
FullText

 

Patzold, S; Luha, O; Hodl, R; Stoschitzky, G; Schmidt, A; Zweiker, R; Zweiker, D; Patzold, D; Pieske, B; Maier, R How durable are the hemodynamic results of transcatheter aortic valve implantation? Single-center four-year follow-up
WIEN KLIN WOCHENSCHR. 2011; 123(17-18):A62-A62. [Poster]
Web of Science

 

Stoschitzky, G; Pieske, B; Stoschitzky, K Long-term Therapy with Nebivolol does not cause Nitrate Tolerance
WIEN KLIN WOCHENSCHR. . 2011; 123(17-18):A56-A56.-42. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; OCT 5-8, 2011; Innsbruck, AUSTRIA. [Poster]
Web of Science

 

Stoschitzky, G; Zweiker, R; Pieske, B; Stoschitzky, K Is the Cross Product of systolic Blood Pressure and Heart Rate a Predictor of Morbidity and Mortality in arterial Hypertension?
WIEN KLIN WOCHENSCHR. . 2011; 123(17-18):A55-A55.-42. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; OCT 5-8, 2011; Innsbruck, AUSTRIA. [Poster]
Web of Science

 

Stoschitzky, G; Zweiker, R; Pieske, B; Stoschitzky, K Variable beta-blocking Effects of Metoprolol, Bisoprolol and Carvedilol
WIEN KLIN WOCHENSCHR. . 2011; 123(17-18):A55-A55.-42. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; OCT 5-8, 2011; Innsbruck, AUSTRIA. [Poster]
Web of Science

 

Blazek, S; Vollmann, R; Simbrunner, J; Luha, O; Hoedl, R; Stoschitzky, G; Pieske, B; Maier, R Detection of subclinical periprocedural microembolic cerebral lesions in transcatheter aortic valve implantation, a cerebral magnetic resonance imaging study
WIEN KLIN WOCHENSCHR. 2010; 122(17-18): A28-A28. [Oral Communication]
Web of Science

 

Blazek, S; Vollmann, R; Simbrunner, J; Luha, O; Hoedl, R; Stoschitzky, G; Pieske, B; Maier, R Cerebral magnetic resonance imaging unmasks microembolic cerebral lesions after transcatheter aortic valve implantation.
EUR HEART J. 2010; 31: 145-146. [Oral Communication]
Web of Science

 

Hödl, R; Schmidt, S; Luha, O; Watzinger, N; Stoschitzky, G; Pieske, B; Maier, R X-ray dose, blood loss, dose of radiocontrast agent and renal function in a series of 100 consecutive transcatheter aortic valve implantation patients
WIEN KLIN WOCHENSCHR. 2010; 122(17-18):A26-A26. [Poster]
Web of Science

 

Maier, R; Hoedl, R; Stoschitzky, G; Grabenwoeger, M; Pollak, J; Blazek, S; Paetzold, D; Watzinger, N; Pieske, B; Luha, O Feasibility and Durability of Percutaneous Aortic Valve Replacement: 30-day and 1-year Outcomes
CIRCULATION. 2010; 122(2): 0128 [Poster]
Web of Science

 

Stoschitzky, G; Maier, R; Hoedl, R; Stoschitzky, K; Pieske, B; Luha, O Echocardiographic follow-up one year and two years after transcatheter aortic valve implantation.
EUR HEART J. 2010; 31: 863-864. [Poster]
Web of Science

 

Blazek, S; Stoschitzky, G; Hodl, R; Patzold, A; Schmidt, A; Watzinger, N; Pieske, B; Luha, O; Maier, R 30-day and one-year outcomes after percutaneous aortic valve replacement: an echocardiographic follow-up study
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A30-A30.-40. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 17-19, 2009; Vienna, Austria. [Oral Communication]
Web of Science

 

Fruhwald, FM; Kollmann, A; Watzinger, N; Pätzold, D; Stoschitzky, G; Schmidt, A Prognose ambulanter Patienten mit Herzinsuffizienz an der Kardiologie Graz: Daten aus dem Herzinsuffizenz-Register
Journal für Kardiologie2009; 16(5-6):181-181.-Jahrestaung der Österreichischen Kardiologischen Gesellschaft (ÖKG); Juni, 3-6, 2009; Salzburg. [Poster]

 

Hödl, R; Maier, R; Stoschitzky, G; Lischnig, M; Perl, S; Luha, O A case of complicated transcatheter aortic valve implantation (TAVI).
J Kardiol 2009; 16(5-6):189-189.-Jahrestagung der Österreichischen Kardiologischen Gesellschaft; JUN 3-6, 2009; Salzburg, AUSTRIA. [Poster]

 

Maier, R; Hödl, R; Stoschitzky, G; Watzinger, N; Oberwalder, P; Pieske, B; Luha, O Percutaneous aortic valve replacement: from feasibility to durability.
Kardiologie 2009 Kongress; MAR 6-7, 2009; Innsbruck, AUSTRIA. 2009. [Poster]

 

Maier, R; Hoedl, R; Stoschitzky, G; Watzinger, N; Blazek, S; Schmidt, A; Paetzold, D; Pieske, B; Luha, O Feasibility and Durability of Percutaneous Aortic Valve Replacement: 30-Day and One-Year Outcomes.
Program & Live Cases iCi & CSI 2009; 146-147.-Congenital & Structural Interventions; JUL 9-11, 2009; Frankfurt, GERMANY. [Poster]

 

Maier, R; Stoschitzky, G; Hödl, R; Watzinger, N; Blazek, S; Schmidt, A; Pätzold, D; Pieske, B; Luha, O From feasibility to durability: 30-day and one-year outcomes after percutaneous aortic valve replacement.
J Kardiol 2009; 16(5-6):191-191.-Jahrestagung der Österreichischen Kardiologischen Gesellschaft; JUN 3-6, 2009; Salzburg, AUSTRIA. [Oral Communication]

 

Maier, R; Stoschitzky, G; Hoedl, R; Watzinger, N; Blazek, S; Schmidt, A; Paetzold, D; Oberwalder, P; Pieske, B; Luha, O From feasibility to durability: 30-day and one-year outcomes after percutaneous aortic valve replacement.
CRC 2009; - 17th Annual Meeting of the Alpe Adria Association of Cardiology; MAY 8 - 9; Dresden, GERMANY. [Poster]

 

Maier, R; Stoschitzky, G; Hoedl, R; Watzinger, N; Blazek, S; Schmidt, A; Paetzold, D; Oberwalder, P; Pieske, B; Luha, O From feasibility to durability: 30-day and one-year outcomes after percutaneous aortic valve replacement.
Abstractbook 2009; - Joint Meeting (27th Cardiovascular Surgical Symposium & 4th Cardiac Surgery Update and Progress); FEB 28 - MAR 7, 2009; Zuers, AUSTRIA. [Oral Communication]

 

Maier, RM; Hoedl, R; Stoschitzky, G; Watzinger, N; Blazek, S; Oberwalder, PJ; Pieske, BM; Luha, O Percutaneous aortic valve replacement: a new treatment option for high-risk patients with symptomatic severe aortic stenosis.
Eur Surg 2009; 41(Supp):91-92.-50th Annual Meeting of the Austrian Society of Surgery; JUN 18-20, 2009; Vienna, AUSTRIA. [Oral Communication]

 

Stoschitzky, G; Luha, O; Hoedl, R; Paetzold, D; Schmidt, A; Watzinger, N; Blazek, S; Pieske, B; Maier, R 30-day and one-year outcomes after percutaneous aortic valve replacement: an echocardiographic follow-up study.
Echocardiography Today and Tomorrow; JUN 22-26, 2009; St. Wolfgang, AUSTRIA. 2009. [Poster]

 

Stoschitzky, G; Maier, R; Hoedl, R; Stoschitzky, K; Pieske, B; Luha, O Echocardiographic follow-up one year after percutaneous aortic valve replacement.
Eur Heart J 2009; 30(Supp):936-936.-ESC Congress 2009; AUG 29 - Sep 2, 2009; Barcelona, SPAIN. [Poster]

 

Maier, R; Hödl, R; Binder, J; Stoschitzky, G; Schmidt, A; Watzinger, N; Brussee, H; Pieske, B; Luha, O Percutaneous aortic valve replacement in an 82-year-old patient 17 years after mitral valve replacement.
Iran Cardiovasc Res J 2008; -2nd Iran-Arab Cardiology Conference; MAR 21-23, 2008; Dubai, UNITED ARAB EMIRATES. [Oral Communication]

 

Maier, R; Hödl, R; Binder, J; Stoschitzky, G; Schmidt, A; Watzinger, N; Brussee, H; Pieske, B; Luha, O Percutaneous aortic valve replacement for severe symptomatic aortic stenosis in high-risk patients: Initial experience with the CoreValve ReValvingTM system.
Iran Cardiovasc Res J 2008; -2nd Iran-Arab Cardiology Conference; MAR 21-23, 2008; Dubai, UNITED ARAB EMIRATES. [Oral Communication]

 

Maier, R; Hödl, R; Stoschitzky, G; Watzinger, N; Luha, O Percutaneous aortic valve replacement for severe symptomatic aortic stenosis: an emerging new treatment option for high-risk patients.
WIEN KLIN WOCHENSCHR. 2008; 120(15-16):A53-A53.- 39. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 17-20, 2008; Graz, AUSTRIA. [Poster]
Web of Science

 

Maier, R; Hödl, R; Stoschitzky, G; Watzinger, N; Schmidt, A; Binder, J; Oberwalder, P; Brussee, H; Pieske, B; Luha, O Percutaneous aortic valve replacement for severe symptomatic aortic stenosis: An emerging new treatment option for high-risk patients.
J Kardiol 2008; 15(5-6):187(2)-187(2).-Jahrestagung der Österreichischen Kardiologischen Gesellschft; MAY 28-31, 2008; Salzburg, AUSTRIA. [Poster]

 

Maier, R; Hödl, R; Stoschitzky, G; Watzinger, N; Schmidt, A; Blazek, S; Oberwalder, P; Pieske, B; Luha, O Percutaneous Aortic Valve Replacement: A New Treatment Option for High-Risk Patients with Symptomatic Severe Aortic Stenosis.
Lijec Vjesn 2008; 130: 76-77.- 7th Congress of the Croatian Cardiac Society; OCT 16-19, 2008; Opatija, CROATIA. [Oral Communication]

 

Maier, R; Hödl, R; Stoschitzky, G; Watzinger, N; Schmidt, A; Oberwalder, P; Pieske, B; Luha, O Percutaneous aortic valve replacement for severe symptomatic aortic stenosis in high-risk patients: Initial experience with the CoreValve ReValvingTM system.
Cardiac Surgery Update and Progress - CSUP; MAR 29 - APR 5, 2008; Lech, AUSTRIA. 2008. [Oral Communication]

 

Maier, R; Hödl, R; Stoschitzky, G; Watzinger, N; Schmidt, A; Oberwalder, P; Pieske, B; Luha, O Percutaneous aortic valve replacement for severe symptomatic aortic stenosis in high-risk patients: Initial experience with the CoreValve ReValvingTM system.
Cardiac Surgery Update and Progress - CSUP; MAR 29 - APR 5, 2008; Lech, AUSTRIA. 2008. [Poster]

 

Maier, R; Hoedl, R; Stoschitzky, G; Watzinger, N; Oberwalder, P; Pieske, B; Luha, O Percutaneous aortic valve replacement: an emerging new treatment option for high-risk patients with severe symptomatic aortic stenosis.
Arch Cardiol Méx 2008; 78(Supp):3-5.- XIV Congreso de la Sociedad Latinoamericana de Cardiologia Intervencionista (SOLACI); AUG 6-8, 2008; Cancun, MEXICO. [Oral Communication]

 

Maier, R; Hoedl, R; Stoschitzky, G; Watzinger, N; Schmidt, A; Binder, J; Oberwalder, P; Brussee, H; Pieske, B; Luha, O Percutaneous aortic valve replacement for severe symptomatic aortic stenosis: an emerging new treatment option for high-risk patients.
Eur Heart J 2008; 29(Supp):62-63.- Congress of the European Society of Cardiology; AUG 30 - SEP 3, 2008; Munich, GERMANY. [Poster]

 

Maier, R; Stoschitzky, G; Hoedl, R; Watzinger, N; Schmidt, A; Blazek, S; Pieske, B; Luha, O Percutaneous aortic valve replacement: echocardiography for patient selection and follow-up.
Eur J Echocardiography 2008; 9(Supp):S136-S136.- Euroecho 2008; DEC 10-13, 2008; Lyon, FRANCE. [Poster]

 

Maier, RM; Hoedl, R; Stoschitzky, G; Watzinger, N; Schmidt, AG; Blazek, S; Oberwalder, PJ; Pieske, B; Luha, O Percutaneous Aortic Valve Replacement for Severe Symptomatic Aortic Stenosis in High-Risk Patients: One-Year Experience with the CoreValve Revalving (TM) System
AMER J CARDIOL. 2008; 102(8A):235I-235I.-12th Annual Transcatheter Cardiovascular Therapeutics Conference; OCT 12-17, 2008; Washington, DC, USA.
Web of Science

 

Stoschitzky, G; Hödl, R; Watzinger, N; Oberwalder, P; Pieske, B; Luha, O; Maier, R Percutaneous aortic valve replacement for severe symptomatic aortic stenosis: Patient selection and management.
J Kardiol 2008; 15(5-6):187(1)-187(1).-Jahrestagung der Österreichischen Kardiologischen Gesellschaft; MAY 28-31, 2008; Salzburg, AUSTRIA. [Poster]

 

Stoschitzky, K; Stoschitzky, G; Zweiker, R The rate pressure product - A predictor of outcome in arterial hypertension?
J HYPERTENSION. 2008; 26: S360-S360. [Poster]
Web of Science

 

Maier, R; Mavriqi, F; Luha, O; Paetzold, D; Watzinger, N; Stoschitzky, G; Gamillscheg, A; Niederkorn, K; Beitzke, A; Horner, S Incidence of recurrent cerebral embolic events after patent foramen ovale and atrial septal defect transcatheter closure.
Eur Heart J 2007; 28(Supp):452-452.-Congress of the European Society of Cardiology; SEP 1-5, 2007; Vienna, AUSTRIA. [Poster]

 

Stoschitzky, G; Maier, R; Lercher, P; Brussee, H; Zweiker, R; Watzinger, N; Fruhwald, FM; Stoschitzky, K Different beta-blocking effects of metoprolol, bisoprolol and carvedilol.
EUR J HEART FAIL. 2007; 6: 122-122.-Heart Failure 2007; JUN 9-12, 2007; Hamburg, Germany. Doi: 10.1016/S1567-4215(07)60342-7 [Poster]
Web of Science FullText FullText_MUG

 

Stoschitzky, K; Stoschitzky, G; Zweiker, R; Brussee, H Is the effect of a drug on the rate pressure product its best predictor of outcome in arterial hypertension?
CARDIOVASC DRUG THERAPY. 2007; 21: S21-S21. [Poster]
Web of Science

 

Stoschitzky, K; Stoschitzky, G; Zweiker, R; Maier, R; Lercher, P; Watzinger, N; Fruhwald, FM; Brussee, H Different beta-blockers show different effects.
CARDIOVASC DRUG THERAPY. 2007; 21: S12-S12. [Poster]
Web of Science

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum